Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Kate Sleeth"'
Autor:
Thomas Helleday, Nicola J. Curtin, Sven Rottenberg, Ricky A. Sharma, Adrian L. Harris, Ariena Kersbergen, Evgenia Gubanova, Cecilia Lundin, Evan A. Mulligan, Vicky Chatzakos, Kate Sleeth, Rafal Zur, Ponnari Gottipati, Nicholas Pedley, Suzanne Kyle, Ivaylo Stoimenov, Janneke E. Jaspers, Tatjana Djurenovic, Huw D. Thomas, Natalia Issaeva
Supplementary Figure 3 from 6-Thioguanine Selectively Kills BRCA2-Defective Tumors and Overcomes PARP Inhibitor Resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e67dc7b078b192391de4e70c66a94ca
https://doi.org/10.1158/0008-5472.22382102
https://doi.org/10.1158/0008-5472.22382102
Autor:
Thomas Helleday, Nicola J. Curtin, Sven Rottenberg, Ricky A. Sharma, Adrian L. Harris, Ariena Kersbergen, Evgenia Gubanova, Cecilia Lundin, Evan A. Mulligan, Vicky Chatzakos, Kate Sleeth, Rafal Zur, Ponnari Gottipati, Nicholas Pedley, Suzanne Kyle, Ivaylo Stoimenov, Janneke E. Jaspers, Tatjana Djurenovic, Huw D. Thomas, Natalia Issaeva
Supplementary Tables 1-2 from 6-Thioguanine Selectively Kills BRCA2-Defective Tumors and Overcomes PARP Inhibitor Resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b549bd5f49f8c9bbff07c11199ba688
https://doi.org/10.1158/0008-5472.22382087
https://doi.org/10.1158/0008-5472.22382087
Autor:
Thomas Helleday, Nicola J. Curtin, Sven Rottenberg, Ricky A. Sharma, Adrian L. Harris, Ariena Kersbergen, Evgenia Gubanova, Cecilia Lundin, Evan A. Mulligan, Vicky Chatzakos, Kate Sleeth, Rafal Zur, Ponnari Gottipati, Nicholas Pedley, Suzanne Kyle, Ivaylo Stoimenov, Janneke E. Jaspers, Tatjana Djurenovic, Huw D. Thomas, Natalia Issaeva
Supplementary Figure 5 from 6-Thioguanine Selectively Kills BRCA2-Defective Tumors and Overcomes PARP Inhibitor Resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25a984712225efcc84daebea3527414e
https://doi.org/10.1158/0008-5472.22382096
https://doi.org/10.1158/0008-5472.22382096
Autor:
Thomas Helleday, Nicola J. Curtin, Sven Rottenberg, Ricky A. Sharma, Adrian L. Harris, Ariena Kersbergen, Evgenia Gubanova, Cecilia Lundin, Evan A. Mulligan, Vicky Chatzakos, Kate Sleeth, Rafal Zur, Ponnari Gottipati, Nicholas Pedley, Suzanne Kyle, Ivaylo Stoimenov, Janneke E. Jaspers, Tatjana Djurenovic, Huw D. Thomas, Natalia Issaeva
Familial breast and ovarian cancers are often defective in homologous recombination (HR) due to mutations in the BRCA1 or BRCA2 genes. Cisplatin chemotherapy or poly(ADP-ribose) polymerase (PARP) inhibitors were tested for these tumors in clinical tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04bc39e6e5162691364807bc0faf3151
https://doi.org/10.1158/0008-5472.c.6500099.v1
https://doi.org/10.1158/0008-5472.c.6500099.v1
Autor:
Katherine A. Vallis, Mark A. Hill, Kate Sleeth, Ketan Shah, James Thompson, Sonali Darbar, Veerle Kersemans, Bart Cornelissen
Supplementary Figure Legends 1-6 from Imaging DNA Damage In Vivo Using γH2AX-Targeted Immunoconjugates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::697ce831ad09cef39deba4d50051e65b
https://doi.org/10.1158/0008-5472.22387656
https://doi.org/10.1158/0008-5472.22387656
Autor:
Katherine A. Vallis, Mark A. Hill, Kate Sleeth, Ketan Shah, James Thompson, Sonali Darbar, Veerle Kersemans, Bart Cornelissen
Supplementary Figures 1-6 from Imaging DNA Damage In Vivo Using γH2AX-Targeted Immunoconjugates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7269c501e9c9bf495435851d1a993bcb
https://doi.org/10.1158/0008-5472.22387653
https://doi.org/10.1158/0008-5472.22387653
Autor:
Thomas Helleday, Nicola J. Curtin, Sven Rottenberg, Ricky A. Sharma, Adrian L. Harris, Ariena Kersbergen, Evgenia Gubanova, Cecilia Lundin, Evan A. Mulligan, Vicky Chatzakos, Kate Sleeth, Rafal Zur, Ponnari Gottipati, Nicholas Pedley, Suzanne Kyle, Ivaylo Stoimenov, Janneke E. Jaspers, Tatjana Djurenovic, Huw D. Thomas, Natalia Issaeva
Supplementary Figure 1 from 6-Thioguanine Selectively Kills BRCA2-Defective Tumors and Overcomes PARP Inhibitor Resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::865839a2fb72258a36b087d22abc08e5
https://doi.org/10.1158/0008-5472.22382108.v1
https://doi.org/10.1158/0008-5472.22382108.v1
Autor:
Thomas Helleday, Nicola J. Curtin, Sven Rottenberg, Ricky A. Sharma, Adrian L. Harris, Ariena Kersbergen, Evgenia Gubanova, Cecilia Lundin, Evan A. Mulligan, Vicky Chatzakos, Kate Sleeth, Rafal Zur, Ponnari Gottipati, Nicholas Pedley, Suzanne Kyle, Ivaylo Stoimenov, Janneke E. Jaspers, Tatjana Djurenovic, Huw D. Thomas, Natalia Issaeva
Supplementary Figure 7 from 6-Thioguanine Selectively Kills BRCA2-Defective Tumors and Overcomes PARP Inhibitor Resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89578ec6695849341bfa6a39785815ab
https://doi.org/10.1158/0008-5472.22382090
https://doi.org/10.1158/0008-5472.22382090
Autor:
Thomas Helleday, Nicola J. Curtin, Sven Rottenberg, Ricky A. Sharma, Adrian L. Harris, Ariena Kersbergen, Evgenia Gubanova, Cecilia Lundin, Evan A. Mulligan, Vicky Chatzakos, Kate Sleeth, Rafal Zur, Ponnari Gottipati, Nicholas Pedley, Suzanne Kyle, Ivaylo Stoimenov, Janneke E. Jaspers, Tatjana Djurenovic, Huw D. Thomas, Natalia Issaeva
Supplementary Figure 2 from 6-Thioguanine Selectively Kills BRCA2-Defective Tumors and Overcomes PARP Inhibitor Resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ebea9bd4ef568e0cedabefa3e81abad
https://doi.org/10.1158/0008-5472.22382105
https://doi.org/10.1158/0008-5472.22382105
Autor:
Thomas Helleday, Nicola J. Curtin, Sven Rottenberg, Ricky A. Sharma, Adrian L. Harris, Ariena Kersbergen, Evgenia Gubanova, Cecilia Lundin, Evan A. Mulligan, Vicky Chatzakos, Kate Sleeth, Rafal Zur, Ponnari Gottipati, Nicholas Pedley, Suzanne Kyle, Ivaylo Stoimenov, Janneke E. Jaspers, Tatjana Djurenovic, Huw D. Thomas, Natalia Issaeva
Supplementary Figure 6 from 6-Thioguanine Selectively Kills BRCA2-Defective Tumors and Overcomes PARP Inhibitor Resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07638122287bddfd668b10d59bda9fc9
https://doi.org/10.1158/0008-5472.22382093.v1
https://doi.org/10.1158/0008-5472.22382093.v1